Second Sight Med

EYES NASDAQ
0.7100
-0.1600
-18.39%
盘后: 0.7299 +0.0199 +2.80% 16:39 05/23 EDT
开盘
0.8500
昨收
0.8700
最高
0.8500
最低
0.7000
成交量
59.54万
成交均量(3M)
34.85万
52周最高
2.250
52周最低
0.6351
换手率
0.48%
市值
8,818.06万
分时
5日
1月
3月
1年
5年

评论

暂无数据

相关股票

微牛行情栏目提供Second Sight Med EYES股票价格,Second Sight Med股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Second Sight Medical Products, Inc. is engaged in developing, manufacturing and marketing prosthetic devices that restore vision to blind individuals. The Company intends to develop Orion Visual Cortical Prosthesis which provides useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease or forms of cancer and trauma. Its product, The Argus II Retinal Prosthesis System (The Argus II) provides electrical stimulation of the retina to induce visual perception in blind individuals and helps in treating outer retinal degenerations, such as retinitis pigmentosa (RP). The Argus II System provides an artificial form of vision that differs from the vision of people with normal sight. The Company's Argus II System employs electrical stimulation to bypass degenerated photoreceptor cells and to stimulate remaining viable retinal cells thereby inducing visual perception in blind individuals.
展开 >

最近浏览

名称
价格
涨跌幅